Employees: 8,962
Size Blue Sail Medical (002382.SZ) is a China Industrials company (Miscellaneous Manufacturing) with a market value of $861M, the 2598th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥5.64 on 6 Nov 2026.
Performance Over six months the shares fell 24.1%, against -13.0% for the median peer and -16.4% for the China market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 22.8% over the last twelve months (peer median +4.3%); the operating margin is 7.0% (peer median 10.0%).
Valuation It trades at 11.8× forward earnings against a peer median of 24.7× (2nd cheapest of 14).
Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is -6%, so the hurdle is -0 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 0.8 points above its cost of capital (5.0% WACC).
Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥7.10B | CN¥5.73B | CN¥6.24B | CN¥4.92B | CN¥4.89B |
| Revenue growth | — | -8% | +27% | +1% | — |
| Gross profit | CN¥2.23B | CN¥787M | CN¥921M | CN¥502M | CN¥386M |
| EBITDA | n/a | CN¥254M | CN¥326M | -CN¥27.7M | -CN¥141M |
| Net income | -CN¥315M | -CN¥759M | -CN¥446M | -CN¥568M | -CN¥372M |
| Free cash flow | CN¥526M | -CN¥73.1M | -CN¥632M | -CN¥816M | -CN¥364M |
| Capital expenditure | CN¥399M | CN¥553M | CN¥774M | CN¥774M | CN¥897M |
| Total debt | CN¥2.71B | CN¥5.45B | CN¥5.18B | CN¥4.04B | CN¥3.21B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002382.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -14.3% | -8.3% | 6th lowest of 21 |
| 6-month return | -24.1% | -13.0% | 5th lowest of 21 |
| Distance from 52-week high | -36.7% | -34.3% | 9th lowest of 21 |
| Revenue growth (TTM) | +22.8% | +4.3% | highest of 21 |
| Operating margin | 7.0% | 10.0% | 10th lowest of 21 |
| Forward P/E | 11.8× | 24.7× | 2nd cheapest of 14 |
| Growth the price implies (Req g, 7 yrs) | -6.5% | 9.8% | 3rd least demanding of 15 |
| Growth delivered (Del g) | -6.1% | +4.3% | 2nd lowest of 15 |
| Hurdle (Req g minus delivered) | -0.4 pp | +3.6 pp | 6th least demanding of 15 |
| ROIC minus cost of capital | +0.8 pp | -0.6 pp | 9th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Blue Sail Medical 002382.SZ | China | $861M | -24% | +23% | 7% | 11.8× | -6.5% | -6.1% |
| Shenzhen Jame Technology 300868.SZ | China | $878M | -36% | +8% | -7% | n/a | n/a | n/a |
| Genuit GEN.L | United Kingdom | $897M | +8% | +4% | 12% | 12.1× | 12.4% | +8.6% |
| Jiangsu Changhai Composite Materials 300196.SZ | China | $897M | -25% | +3% | 11% | 17.9× | 3.8% | +9.0% |
| Riverstone AP4.SI | Singapore | $824M | -13% | -4% | 25% | 15.5× | 2.1% | -12.8% |
| Zhejiang Goldensea Hi-Tech 603311.SS | China | $823M | +28% | +3% | 7% | 59.6× | n/a | n/a |
| Zhejiang Kaier New Materials 300234.SZ | China | $816M | +73% | -17% | -9% | n/a | n/a | n/a |
| Hubei Huaqiang High-Tech 688151.SS | China | $800M | -22% | +13% | -5% | n/a | 47.9% | -5.6% |
| Changyuan Technology 600525.SS | China | $799M | -24% | +7% | -7% | n/a | -12.4% | +5.1% |
| Unilumin 300232.SZ | China | $796M | -23% | +1% | 0% | 32.5× | 6.4% | +10.3% |
| Finolex Industries FINPIPE.NS | India | $932M | -20% | +3% | 14% | 16.4× | 13.0% | +3.5% |
| RHI Magnesita India RHIM.NS | India | $789M | -13% | +8% | 7% | 25.4× | 27.1% | +24.1% |
| Apex Dynamics 4583.TW | Taiwan | $775M | -58% | +14% | 33% | 24.3× | 4.5% | +1.1% |
| Shanghai Yanpu Precision Technology (Group) 605128.SS | China | $978M | -9% | +3% | 9% | 27.1× | 15.4% | +25.0% |
| Fuling Technology 001356.SZ | China | $756M | -22% | +17% | 6% | n/a | n/a | n/a |
| Shanghai Hajime Advanced Material Technology 301000.SZ | China | $986M | -1% | +4% | 16% | 40.9× | n/a | n/a |
| Sichuan Goldstone Asia Pharmaceutical 300434.SZ | China | $745M | +8% | -1% | 18% | n/a | 12.2% | +6.2% |
| Daoming Optics & Chemical 002632.SZ | China | $740M | -28% | -10% | 12% | n/a | 7.5% | +3.3% |
| INDUS INH.DE | Germany | $1.03B | +11% | +8% | 13% | 7.0× | -6.8% | +2.2% |
| Jiangsu Boiln Plastics 301003.SZ | China | $688M | -11% | +7% | 20% | 24.7× | 21.2% | +3.6% |
| Jinhua Chunguang Technology 603657.SS | China | $687M | +16% | +9% | -3% | 45.2× | n/a | n/a |